Exercise of First Tranche of Put Option Agreement

Summary by AI ^BETAClose X

Roadside Real Estate PLC has confirmed the exercise of the first tranche of its put option agreement with CGV Ventures 1 Ltd, representing a 14% stake in Cambridge Sleep Sciences. The company anticipates receiving £14 million by the end of April 2026, which will then facilitate the acquisition of D. A. Roberts Fuels Ltd.

Disclaimer*

Roadside Real Estate PLC

31 March 2026

Roadside Real Estate PLC

("Roadside", the "Company" and the "Group")

Exercise of First Tranche of Put Option Agreement

Roadside (AIM: ROAD) confirms that, pursuant to the amended put option agreement with CGV Ventures 1 Ltd ("CGV") in regard to the sale of the Company's remaining 48% investment in Cambridge Sleep Sciences ("CSS") - announced on 9 February 2026 - the put option over the first tranche, representing 14% of the issued share capital of CSS, has been exercised.

CGV is undertaking the necessary drawdown procedures from its underlying investors, with the consideration of £14 million expected to be received by the Company by the end of April 2026. The Company will complete the acquisition of D. A. Roberts Fuels Ltd shortly after the receipt of the funds from CGV.

Enquiries:

Roadside Real Estate PLC

Steve Carson, Chairman

Charles Dickson, Chief Executive Officer

Douglas Benzie, Chief Financial Officer

c/o Montfort

Montfort

Ann-marie Wilkinson

Alex Everett

+44 (0)7730 623815

+44 (0)7780 431533

Cavendish Capital Markets Limited (Nomad & Joint Corporate Broker)

Matt Goode / Seamus Fricker / Elysia Bough (Corporate Finance)

Matt Lewis / Harriet Ward (ECM)

+44 (0) 20 7220 0500

Shore Capital (Joint Corporate Broker)

Ben Canning (Corporate Broking)

+44 (0)20 7408 4050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END